699 results match your criteria: "Mitchell Cancer Institute[Affiliation]"
Gynecol Oncol
November 2022
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology University of Minnesota, Minneapolis, MN, USA. Electronic address:
Objective: HER2 is an important prognostic and therapeutic target in uterine serous carcinoma (USC). Optimal HER2 testing platforms have not been defined and guidelines for testing have changed over time. Our objective is to assess the concordance of HER2 positivity based on chromogenic in situ hybridization (CISH), immunohistochemistry (IHC), and next generation sequencing (NGS) and to determine the rate of downstream mutations that may affect response to HER2 directed therapy.
View Article and Find Full Text PDFNAR Genom Bioinform
September 2022
Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.
The Comet or single-cell gel electrophoresis assay is a highly sensitive method to measure cellular, nuclear genome damage. However, low throughput can limit its application for large-scale studies. To overcome these limitations, a 96-well CometChip platform was recently developed that increases throughput and reduces variation due to simultaneous processing and automated analysis of 96 samples.
View Article and Find Full Text PDFJ Cell Physiol
November 2022
Department of Pathology, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA.
Mitochondria are pivotal organelles that govern cellular energy production through the oxidative phosphorylation system utilizing five respiratory complexes. In addition, mitochondria also contribute to various critical signaling pathways including apoptosis, damage-associated molecular patterns, calcium homeostasis, lipid, and amino acid biosynthesis. Among these diverse functions, the energy generation program oversee by mitochondria represents an immaculate orchestration and functional coordination between the mitochondria and nuclear encoded molecules.
View Article and Find Full Text PDFCancer Lett
November 2022
Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, 36617, United States; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, United States; Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, AL, 36688, United States.
Cancer Lett
October 2022
Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, 36617, USA; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA; Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, AL, 36688, USA.
Cancers (Basel)
July 2022
Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, AL 36688, USA.
Poly(ADP-ribose) (PAR) is a molecular scaffold that aids in the formation of DNA repair protein complexes. Tools to sensitively quantify PAR in live cells have been lacking. We recently described the LivePAR probe (EGFP fused to the RNF146-encoded WWE PAR binding domain) to measure PAR formation at sites of laser micro-irradiation in live cells.
View Article and Find Full Text PDFFront Cell Dev Biol
July 2022
Department of Biochemistry and Molecular Biology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, United States.
The maintenance of human mitochondrial DNA (mtDNA) is critical for proper cellular function as damage to mtDNA, if left unrepaired, can lead to a diverse array of pathologies. Of the pathways identified to participate in DNA repair within the mitochondria, base excision repair (BER) is the most extensively studied. Protein-protein interactions drive the step-by-step coordination required for the successful completion of this pathway and are important for crosstalk with other mitochondrial factors involved in genome maintenance.
View Article and Find Full Text PDFSupport Care Cancer
October 2022
General Internal Medicine Department, The University of Texas M.D. Anderson Cancer Center, TX, Houston, USA.
Cancer patients have an increased risk of developing venous thromboembolic events. Anticoagulation management includes prophylactic or therapeutic doses of low molecular weight heparins (LMWHs) or direct oral anticoagulants (DOACs). However, the management of thrombosis in patients with cancer is complex due to various individual and disease-related factors, including drug-drug interactions (DDIs).
View Article and Find Full Text PDFBr J Cancer
November 2022
Department of Pathology, The Ohio State University, Columbus, OH, 43210, USA.
Background: Resistance to anti-angiogenic therapies targeting vascular endothelial growth factor-A (VEGF-A) stems from VEGF-A independent angiogenesis mediated by other proangiogenic factors. Therefore identifying these factors in colon adenocarcinoma (CA) will reveal new therapeutic targets.
Methods: Neuropeptide Y (NPY) and Y2 receptor (Y2R) expressions in CA were studied by immunohistochemical analysis.
Cancers (Basel)
July 2022
Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, AL 36688, USA.
Glioblastoma multiforme (GBM) is an incurable brain cancer with an average survival of approximately 15 months. Temozolomide (TMZ) is a DNA alkylating agent for the treatment of GBM. However, at least 50% of the patients treated with TMZ show poor response, primarily due to elevated expression of the repair protein O-methylguanine-DNA methyltransferase (MGMT) or due to defects in the mismatch repair (MMR) pathway.
View Article and Find Full Text PDFGynecol Oncol
September 2022
Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, NY, United States of America; Department of Obstetrics and Gynecology, Weill Cornell Medical College, NY, NY, United States of America.
Objective: The Laparoscopic Approach to Cervical Cancer (LACC) trial found that minimally invasive radical hysterectomy compared to open radical hysterectomy compromised oncologic outcomes and was associated with worse progression-free survival (PFS) and overall survival (OS) in early-stage cervical carcinoma. We sought to assess oncologic outcomes at multiple centers between minimally invasive (MIS) radical hysterectomy and OPEN radical hysterectomy.
Methods: This is a multi-institutional, retrospective cohort study of patients with 2009 FIGO stage IA1 (with lymphovascular space invasion) to IB1 cervical carcinoma from 1/2007-12/2016.
Nutrients
July 2022
Nestlé Institute of Health Sciences, Nestlé Research Ltd., EPFL Innovation Park, 1015 Lausanne, Switzerland.
Through evolution, eukaryote organisms have developed the ability to use different molecules as independent precursors to generate nicotinamide adenine dinucleotide (NAD), an essential molecule for life. However, whether these different precursors act in an additive or complementary manner is not truly well understood. Here, we have evaluated how combinations of different NAD precursors influence intracellular NAD levels.
View Article and Find Full Text PDFFront Nutr
June 2022
Department of Nutrition, Dietetics and Hospitality Management, Auburn University, Auburn, AL, United States.
Background: Colorectal cancer in adults 50 years old and younger is increasing in incidence worldwide. Diet may be a modifiable risk factor. The objective of this study was to examine evidence regarding the association between diet and the risk of developing early-onset colorectal cancer (EOCRC) and early-onset colorectal adenomas in young adults.
View Article and Find Full Text PDFLung Cancer
August 2022
Departments of Radiation Oncology and Biostatistics & Information, Mayo Clinic, 200 1st St SW, Rochester, MN, USA. Electronic address:
Objectives: The incidence and predictors of pneumonitis for patients with unresectable, locally advanced non-small cell lung cancer (NSCLC) in the era of consolidation durvalumab have yet to be fully elucidated. In this large single institution analysis, we report the incidence of and factors associated with grade 2 + pneumonitis in NSCLC patients treated with the PACIFIC regimen.
Materials And Methods: We identified all patients treated at our institution with definitive CRT followed by durvalumab from 2018 to 2021.
Trials
June 2022
School of Nursing, University of Alabama at Birmingham (UAB), Birmingham, AL, USA.
Background: Family caregivers play a vital, yet stressful role in managing the healthcare needs and optimizing the quality of life of patients with advanced cancer, from the time they are newly diagnosed until end of life. While early telehealth palliative care has been found to effectively support family caregivers, little work has focused on historically under-resourced populations, particularly African American and rural-dwelling individuals. To address this need, we developed and are currently testing Project ENABLE (Educate, Nurture, Advise, Before Life Ends) Cornerstone, a lay navigator-led, early palliative care coaching intervention for family caregivers of African American and rural-dwelling patients with newly diagnosed advanced cancer.
View Article and Find Full Text PDFMolecules
May 2022
Mitchell Cancer Institute, Department of Pharmacology, College of Medicine, University of South Alabama, 1660 Springhill Avenue, Mobile, AL 36604, USA.
We report the synthesis of vitamin B1, B2, and B3 derived nucleotides and dinucleotides generated either through mechanochemical or solution phase chemistry. Under the explored conditions, adenosine and thiamine proved to be particularly amenable to milling conditions. Following optimization of the chemistry related to the formation pyrophosphate bonds, mixed dinucleotides of adenine and thiamine (vitamin B1), riboflavin (vitamin B2), nicotinamide riboside and 3-carboxamide 4-pyridone riboside (both vitamin B3 derivatives) were generated in good yields.
View Article and Find Full Text PDFBiofabrication
July 2022
Department of Chemical Engineering, Auburn University, Auburn, AL 36849, United States of America.
The development of physiologically relevantcolorectal cancer (CRC) models is vital for advancing understanding of tumor biology. Although CRC patient-derived xenografts (PDXs) recapitulate key patient tumor characteristics and demonstrate high concordance with clinical outcomes, the use of thismodel is costly and low-throughput. Here we report the establishment and in-depth characterization of antissue-engineered CRC model using PDX cells.
View Article and Find Full Text PDFJ Cell Sci
June 2022
Department of Pathology, Ohio State University, Columbus, Ohio 43201, USA.
We have previously demonstrated significant upregulation of dopamine D2 (DAD2) receptor (DRD2) expression on tumor endothelial cells. The dopamine D2 receptors, upon activation, inhibit the proangiogenic actions of vascular endothelial growth factor-A (VEGF-A, also known as vascular permeability factor). Interestingly, unlike tumor endothelial cells, normal endothelial cells exhibit very low to no expression of dopamine D2 receptors.
View Article and Find Full Text PDFPLoS One
May 2022
Department of Nutrition, Dietetics and Hospitality Management, Auburn University, Auburn, AL, United States of America.
Colorectal cancer (CRC) is the third-leading cause of cancer-related deaths in the United States and worldwide. Obesity-a worldwide public health concern-is a known risk factor for cancer including CRC. However, the mechanisms underlying the link between CRC and obesity have yet to be fully elucidated in part because of the molecular heterogeneity of CRC.
View Article and Find Full Text PDFOncogene
June 2022
Cancer Epigenetics Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
Gynecol Oncol
July 2022
Mitchell Cancer Institute, University of South Alabama, Division of Gynecologic Oncology Mobile, AL, United States of America.
Objectives: Disparate outcomes exist between Black and White patients with endometrial cancer (EC). One contributing factor is the disproportionately low representation of Black patients in clinical trials and in tumor molecular profiling studies. Our objective was to investigate molecular profiles of ECs in a cohort with a high proportion of tumors from Black patients.
View Article and Find Full Text PDFBackground: Symptoms in patients with advanced cancer are often inadequately captured during encounters with the healthcare team. Emerging evidence demonstrates that weekly electronic home-based patient-reported symptom monitoring with automated alerts to clinicians reduces healthcare utilization, improves health-related quality of life, and lengthens survival. However, oncology practices have lagged in adopting remote symptom monitoring into routine practice, where specific patient populations may have unique barriers.
View Article and Find Full Text PDFInt J Mol Sci
April 2022
Department of Pharmacology and Toxicology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Dysregulation of DNA repair is a hallmark of cancer, though few cancer-specific mechanisms that drive the overexpression of DNA repair proteins are known. We previously identified STAT3 as a novel transcriptional regulator of X-ray cross-complementing group 1 (XRCC1), an essential scaffold protein in base excision repair in triple-negative breast cancers. We also identified an inducible response to IL-6 and epidermal growth factor stimulation in the non-tumorigenic embryonic kidney cell line HEK293T.
View Article and Find Full Text PDFCurr Protoc
April 2022
Mitchell Cancer Institute, Department of Pharmacology, College of Medicine, University of South Alabama, 1660 Springhill Avenue, Mobile, Alabama.
This article contains a synthetic protocol for solvent-assisted mechanochemical synthesis of a nucleotide dimer. First, a dinucleoside phosphite is prepared by solvent-assisted mechanochemistry via the phosphoramidite method. Second, the dinucleoside phosphite is oxidized to form the dinucleotide under mechanochemical conditions.
View Article and Find Full Text PDF